Market research
INGN Inogen Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 149M
- P/E ratio
- Not available
- Analyst target
- 12.6667
- Dividend yield
- Not available
- Beta
- 1.6
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US45780L1044
- Market cap
- 149M
- P/E ratio
- Not available
- Analyst target
- 12.6667
- Dividend yield
- Not available
- Beta
- 1.6
About
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the INGN discussion.
5 years, 4 months ago
Inogen, Inc is currently in a long term uptrend where the price is trading 30.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Inogen, Inc's total revenue sank by 6.3% to $74M since the same quarter in the previous year.
Its net income has dropped by 272.4% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.9% to $10M since the same quarter in the previous year.
Based on the above factors, Inogen, Inc gets an overall score of 3/5.